Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SAB Biotherapeutics, Inc. | Chief Business Officer | Common Stock | 38.6K | $34K | $0.88 | Oct 22, 2021 | Direct |
SAB Biotherapeutics, Inc. | Chief Business Officer | Earnout Rights (Common Stock) | 15.6K | $18.8K | $1.21 | Oct 22, 2021 | Direct |
SAB Biotherapeutics, Inc. | Chief Business Officer | Earnout Rights (Restricted Stock Units) | 60.2K | Oct 22, 2021 | Direct | ||
SAB Biotherapeutics, Inc. | Chief Business Officer | Employee Stock Option (right to buy) | 23.5K | Mar 16, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SABS | SAB Biotherapeutics, Inc. | Mar 16, 2022 | 1 | $0 | 4 | Mar 18, 2022 | Chief Business Officer |
SABS | SAB Biotherapeutics, Inc. | Oct 22, 2021 | 5 | $0 | 4 | Oct 26, 2021 | Chief Business Officer |
SABS | Big Cypress Acquisition Corp. | Oct 22, 2021 | 0 | $0 | 3 | Oct 22, 2021 | Chief Business Officer |